NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1209512, encodeId=29571209512db, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：2022年1月10日提交；2月18日review结束，大修；3月14修回，第二天送review；4月1日review结束，小修；4月2日修回；4月6日accept。审稿人和编辑都是天使，可能运气太好，没有参考价值。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/36106a7fa35645f6a2c7404a7acbe984/37233b07a082487c8b66591785d9fc87.png, createdBy=7d465433263, createdName=王王王王大腿, createdTime=Fri Apr 08 10:56:00 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800138, encodeId=08f9800138b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：不错的杂志，刚接收了一篇，一审大概1.5个月，给了大修，3个审稿人给的意见很中肯，修回后没过多久就under review，大概10天左右直接accept<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1127, replyNumber=6, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200919/6a097961ca9c42c185295b14179a7194/45794bdef2854b5eac70a38f937a6355.jpg, createdBy=8e512207268, createdName=120c9b2em65(暂无昵称), createdTime=Sun Jun 28 17:02:06 CST 2020, time=2020-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053627, encodeId=67e3105362e9a, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：心血管药物 经验分享：2月份投稿，审稿两个多月，修稿两个多月，两个审稿人的问题也不说清楚，补充实验后，返回编辑，结果拒稿，理由是没有提供原始数据，审稿意见和往来邮件中从来没有提及要提供原始数据，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920b5612598, createdName=ms8000001931272154, createdTime=Wed Sep 22 04:30:06 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146004, encodeId=9fea21460048f, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢;;营养; 经验分享：投稿1月3号 1月13号with editor 2月12日Under review 3月31日修稿通知 6月1日上传修改稿 6月2日-With Editor 6月26日Under review 6月29日决策中 6月30号接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23e45475395, createdName=ms8000000472362345, createdTime=Sun Jul 02 22:41:59 CST 2023, time=2023-07-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127302, encodeId=0c17212e3025d, content=审稿速度:4.0 | 投稿命中率:5.0 经验分享：一生黑。浪费四个月，最后小修后拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a35c6157456, createdName=ms4000001493366416, createdTime=Thu Apr 20 17:55:36 CST 2023, time=2023-04-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1014233, encodeId=c452101423379, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：从送审到接收一共4个月，reviewer给的修改意见都满中肯的，推荐大家试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f66f5413873, createdName=ms3000000954628811, createdTime=Fri Sep 03 10:11:06 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582689, encodeId=58b55826898c, content=投稿3个多月了一直就是under review，效率真的低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/02/b5194c05477f149e6bd8f172e1c2828e.jpg, createdBy=7ceb2052413, createdName=Dr_WangBH, createdTime=Sat Jan 04 00:00:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202822, encodeId=f76d1202822f6, content=想问一下大家，投稿3天好分配了主编，然后过了一周又分配了一个associate editor，现在半个月了还在with editor，有这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33995569878, createdName=ms1000001369889276, createdTime=Tue Mar 15 18:20:52 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096193, encodeId=c78e10961930a, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096194, encodeId=0d6b109619431, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-04-08 王王王王大腿

审稿速度:3.0 | 投稿命中率:95.0
经验分享：2022年1月10日提交；2月18日review结束，大修；3月14修回，第二天送review；4月1日review结束，小修；4月2日修回；4月6日accept。审稿人和编辑都是天使，可能运气太好，没有参考价值。

135 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=1209512, encodeId=29571209512db, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：2022年1月10日提交；2月18日review结束，大修；3月14修回，第二天送review；4月1日review结束，小修；4月2日修回；4月6日accept。审稿人和编辑都是天使，可能运气太好，没有参考价值。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/36106a7fa35645f6a2c7404a7acbe984/37233b07a082487c8b66591785d9fc87.png, createdBy=7d465433263, createdName=王王王王大腿, createdTime=Fri Apr 08 10:56:00 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800138, encodeId=08f9800138b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：不错的杂志，刚接收了一篇，一审大概1.5个月，给了大修，3个审稿人给的意见很中肯，修回后没过多久就under review，大概10天左右直接accept<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1127, replyNumber=6, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200919/6a097961ca9c42c185295b14179a7194/45794bdef2854b5eac70a38f937a6355.jpg, createdBy=8e512207268, createdName=120c9b2em65(暂无昵称), createdTime=Sun Jun 28 17:02:06 CST 2020, time=2020-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053627, encodeId=67e3105362e9a, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：心血管药物 经验分享：2月份投稿，审稿两个多月，修稿两个多月，两个审稿人的问题也不说清楚，补充实验后，返回编辑，结果拒稿，理由是没有提供原始数据，审稿意见和往来邮件中从来没有提及要提供原始数据，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920b5612598, createdName=ms8000001931272154, createdTime=Wed Sep 22 04:30:06 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146004, encodeId=9fea21460048f, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢;;营养; 经验分享：投稿1月3号 1月13号with editor 2月12日Under review 3月31日修稿通知 6月1日上传修改稿 6月2日-With Editor 6月26日Under review 6月29日决策中 6月30号接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23e45475395, createdName=ms8000000472362345, createdTime=Sun Jul 02 22:41:59 CST 2023, time=2023-07-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127302, encodeId=0c17212e3025d, content=审稿速度:4.0 | 投稿命中率:5.0 经验分享：一生黑。浪费四个月，最后小修后拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a35c6157456, createdName=ms4000001493366416, createdTime=Thu Apr 20 17:55:36 CST 2023, time=2023-04-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1014233, encodeId=c452101423379, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：从送审到接收一共4个月，reviewer给的修改意见都满中肯的，推荐大家试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f66f5413873, createdName=ms3000000954628811, createdTime=Fri Sep 03 10:11:06 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582689, encodeId=58b55826898c, content=投稿3个多月了一直就是under review，效率真的低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/02/b5194c05477f149e6bd8f172e1c2828e.jpg, createdBy=7ceb2052413, createdName=Dr_WangBH, createdTime=Sat Jan 04 00:00:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202822, encodeId=f76d1202822f6, content=想问一下大家，投稿3天好分配了主编，然后过了一周又分配了一个associate editor，现在半个月了还在with editor，有这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33995569878, createdName=ms1000001369889276, createdTime=Tue Mar 15 18:20:52 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096193, encodeId=c78e10961930a, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096194, encodeId=0d6b109619431, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2020-06-28 120c9b2em65(暂无昵称)

审稿速度:2.0 | 投稿命中率:50.0
经验分享：不错的杂志，刚接收了一篇，一审大概1.5个月，给了大修，3个审稿人给的意见很中肯，修回后没过多久就under review，大概10天左右直接accept#心血管#

1127 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1209512, encodeId=29571209512db, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：2022年1月10日提交；2月18日review结束，大修；3月14修回，第二天送review；4月1日review结束，小修；4月2日修回；4月6日accept。审稿人和编辑都是天使，可能运气太好，没有参考价值。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/36106a7fa35645f6a2c7404a7acbe984/37233b07a082487c8b66591785d9fc87.png, createdBy=7d465433263, createdName=王王王王大腿, createdTime=Fri Apr 08 10:56:00 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800138, encodeId=08f9800138b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：不错的杂志，刚接收了一篇，一审大概1.5个月，给了大修，3个审稿人给的意见很中肯，修回后没过多久就under review，大概10天左右直接accept<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1127, replyNumber=6, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200919/6a097961ca9c42c185295b14179a7194/45794bdef2854b5eac70a38f937a6355.jpg, createdBy=8e512207268, createdName=120c9b2em65(暂无昵称), createdTime=Sun Jun 28 17:02:06 CST 2020, time=2020-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053627, encodeId=67e3105362e9a, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：心血管药物 经验分享：2月份投稿，审稿两个多月，修稿两个多月，两个审稿人的问题也不说清楚，补充实验后，返回编辑，结果拒稿，理由是没有提供原始数据，审稿意见和往来邮件中从来没有提及要提供原始数据，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920b5612598, createdName=ms8000001931272154, createdTime=Wed Sep 22 04:30:06 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146004, encodeId=9fea21460048f, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢;;营养; 经验分享：投稿1月3号 1月13号with editor 2月12日Under review 3月31日修稿通知 6月1日上传修改稿 6月2日-With Editor 6月26日Under review 6月29日决策中 6月30号接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23e45475395, createdName=ms8000000472362345, createdTime=Sun Jul 02 22:41:59 CST 2023, time=2023-07-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127302, encodeId=0c17212e3025d, content=审稿速度:4.0 | 投稿命中率:5.0 经验分享：一生黑。浪费四个月，最后小修后拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a35c6157456, createdName=ms4000001493366416, createdTime=Thu Apr 20 17:55:36 CST 2023, time=2023-04-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1014233, encodeId=c452101423379, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：从送审到接收一共4个月，reviewer给的修改意见都满中肯的，推荐大家试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f66f5413873, createdName=ms3000000954628811, createdTime=Fri Sep 03 10:11:06 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582689, encodeId=58b55826898c, content=投稿3个多月了一直就是under review，效率真的低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/02/b5194c05477f149e6bd8f172e1c2828e.jpg, createdBy=7ceb2052413, createdName=Dr_WangBH, createdTime=Sat Jan 04 00:00:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202822, encodeId=f76d1202822f6, content=想问一下大家，投稿3天好分配了主编，然后过了一周又分配了一个associate editor，现在半个月了还在with editor，有这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33995569878, createdName=ms1000001369889276, createdTime=Tue Mar 15 18:20:52 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096193, encodeId=c78e10961930a, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096194, encodeId=0d6b109619431, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-09-22 ms8000001931272154

审稿速度:12.0 | 投稿命中率:5.0
偏重的研究方向：心血管药物
经验分享：2月份投稿，审稿两个多月，修稿两个多月，两个审稿人的问题也不说清楚，补充实验后，返回编辑，结果拒稿，理由是没有提供原始数据，审稿意见和往来邮件中从来没有提及要提供原始数据，太坑了

299 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1209512, encodeId=29571209512db, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：2022年1月10日提交；2月18日review结束，大修；3月14修回，第二天送review；4月1日review结束，小修；4月2日修回；4月6日accept。审稿人和编辑都是天使，可能运气太好，没有参考价值。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/36106a7fa35645f6a2c7404a7acbe984/37233b07a082487c8b66591785d9fc87.png, createdBy=7d465433263, createdName=王王王王大腿, createdTime=Fri Apr 08 10:56:00 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800138, encodeId=08f9800138b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：不错的杂志，刚接收了一篇，一审大概1.5个月，给了大修，3个审稿人给的意见很中肯，修回后没过多久就under review，大概10天左右直接accept<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1127, replyNumber=6, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200919/6a097961ca9c42c185295b14179a7194/45794bdef2854b5eac70a38f937a6355.jpg, createdBy=8e512207268, createdName=120c9b2em65(暂无昵称), createdTime=Sun Jun 28 17:02:06 CST 2020, time=2020-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053627, encodeId=67e3105362e9a, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：心血管药物 经验分享：2月份投稿，审稿两个多月，修稿两个多月，两个审稿人的问题也不说清楚，补充实验后，返回编辑，结果拒稿，理由是没有提供原始数据，审稿意见和往来邮件中从来没有提及要提供原始数据，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920b5612598, createdName=ms8000001931272154, createdTime=Wed Sep 22 04:30:06 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146004, encodeId=9fea21460048f, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢;;营养; 经验分享：投稿1月3号 1月13号with editor 2月12日Under review 3月31日修稿通知 6月1日上传修改稿 6月2日-With Editor 6月26日Under review 6月29日决策中 6月30号接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23e45475395, createdName=ms8000000472362345, createdTime=Sun Jul 02 22:41:59 CST 2023, time=2023-07-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127302, encodeId=0c17212e3025d, content=审稿速度:4.0 | 投稿命中率:5.0 经验分享：一生黑。浪费四个月，最后小修后拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a35c6157456, createdName=ms4000001493366416, createdTime=Thu Apr 20 17:55:36 CST 2023, time=2023-04-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1014233, encodeId=c452101423379, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：从送审到接收一共4个月，reviewer给的修改意见都满中肯的，推荐大家试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f66f5413873, createdName=ms3000000954628811, createdTime=Fri Sep 03 10:11:06 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582689, encodeId=58b55826898c, content=投稿3个多月了一直就是under review，效率真的低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/02/b5194c05477f149e6bd8f172e1c2828e.jpg, createdBy=7ceb2052413, createdName=Dr_WangBH, createdTime=Sat Jan 04 00:00:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202822, encodeId=f76d1202822f6, content=想问一下大家，投稿3天好分配了主编，然后过了一周又分配了一个associate editor，现在半个月了还在with editor，有这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33995569878, createdName=ms1000001369889276, createdTime=Tue Mar 15 18:20:52 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096193, encodeId=c78e10961930a, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096194, encodeId=0d6b109619431, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2023-07-02 ms8000000472362345 来自北京

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：代谢;;营养;
经验分享：投稿1月3号
1月13号with editor
2月12日Under review
3月31日修稿通知
6月1日上传修改稿
6月2日-With Editor
6月26日Under review
6月29日决策中
6月30号接收

50 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1209512, encodeId=29571209512db, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：2022年1月10日提交；2月18日review结束，大修；3月14修回，第二天送review；4月1日review结束，小修；4月2日修回；4月6日accept。审稿人和编辑都是天使，可能运气太好，没有参考价值。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/36106a7fa35645f6a2c7404a7acbe984/37233b07a082487c8b66591785d9fc87.png, createdBy=7d465433263, createdName=王王王王大腿, createdTime=Fri Apr 08 10:56:00 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800138, encodeId=08f9800138b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：不错的杂志，刚接收了一篇，一审大概1.5个月，给了大修，3个审稿人给的意见很中肯，修回后没过多久就under review，大概10天左右直接accept<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1127, replyNumber=6, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200919/6a097961ca9c42c185295b14179a7194/45794bdef2854b5eac70a38f937a6355.jpg, createdBy=8e512207268, createdName=120c9b2em65(暂无昵称), createdTime=Sun Jun 28 17:02:06 CST 2020, time=2020-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053627, encodeId=67e3105362e9a, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：心血管药物 经验分享：2月份投稿，审稿两个多月，修稿两个多月，两个审稿人的问题也不说清楚，补充实验后，返回编辑，结果拒稿，理由是没有提供原始数据，审稿意见和往来邮件中从来没有提及要提供原始数据，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920b5612598, createdName=ms8000001931272154, createdTime=Wed Sep 22 04:30:06 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146004, encodeId=9fea21460048f, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢;;营养; 经验分享：投稿1月3号 1月13号with editor 2月12日Under review 3月31日修稿通知 6月1日上传修改稿 6月2日-With Editor 6月26日Under review 6月29日决策中 6月30号接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23e45475395, createdName=ms8000000472362345, createdTime=Sun Jul 02 22:41:59 CST 2023, time=2023-07-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127302, encodeId=0c17212e3025d, content=审稿速度:4.0 | 投稿命中率:5.0 经验分享：一生黑。浪费四个月，最后小修后拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a35c6157456, createdName=ms4000001493366416, createdTime=Thu Apr 20 17:55:36 CST 2023, time=2023-04-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1014233, encodeId=c452101423379, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：从送审到接收一共4个月，reviewer给的修改意见都满中肯的，推荐大家试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f66f5413873, createdName=ms3000000954628811, createdTime=Fri Sep 03 10:11:06 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582689, encodeId=58b55826898c, content=投稿3个多月了一直就是under review，效率真的低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/02/b5194c05477f149e6bd8f172e1c2828e.jpg, createdBy=7ceb2052413, createdName=Dr_WangBH, createdTime=Sat Jan 04 00:00:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202822, encodeId=f76d1202822f6, content=想问一下大家，投稿3天好分配了主编，然后过了一周又分配了一个associate editor，现在半个月了还在with editor，有这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33995569878, createdName=ms1000001369889276, createdTime=Tue Mar 15 18:20:52 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096193, encodeId=c78e10961930a, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096194, encodeId=0d6b109619431, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2023-04-20 ms4000001493366416 来自北京

审稿速度:4.0 | 投稿命中率:5.0
经验分享：一生黑。浪费四个月，最后小修后拒稿

46 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1209512, encodeId=29571209512db, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：2022年1月10日提交；2月18日review结束，大修；3月14修回，第二天送review；4月1日review结束，小修；4月2日修回；4月6日accept。审稿人和编辑都是天使，可能运气太好，没有参考价值。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/36106a7fa35645f6a2c7404a7acbe984/37233b07a082487c8b66591785d9fc87.png, createdBy=7d465433263, createdName=王王王王大腿, createdTime=Fri Apr 08 10:56:00 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800138, encodeId=08f9800138b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：不错的杂志，刚接收了一篇，一审大概1.5个月，给了大修，3个审稿人给的意见很中肯，修回后没过多久就under review，大概10天左右直接accept<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1127, replyNumber=6, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200919/6a097961ca9c42c185295b14179a7194/45794bdef2854b5eac70a38f937a6355.jpg, createdBy=8e512207268, createdName=120c9b2em65(暂无昵称), createdTime=Sun Jun 28 17:02:06 CST 2020, time=2020-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053627, encodeId=67e3105362e9a, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：心血管药物 经验分享：2月份投稿，审稿两个多月，修稿两个多月，两个审稿人的问题也不说清楚，补充实验后，返回编辑，结果拒稿，理由是没有提供原始数据，审稿意见和往来邮件中从来没有提及要提供原始数据，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920b5612598, createdName=ms8000001931272154, createdTime=Wed Sep 22 04:30:06 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146004, encodeId=9fea21460048f, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢;;营养; 经验分享：投稿1月3号 1月13号with editor 2月12日Under review 3月31日修稿通知 6月1日上传修改稿 6月2日-With Editor 6月26日Under review 6月29日决策中 6月30号接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23e45475395, createdName=ms8000000472362345, createdTime=Sun Jul 02 22:41:59 CST 2023, time=2023-07-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127302, encodeId=0c17212e3025d, content=审稿速度:4.0 | 投稿命中率:5.0 经验分享：一生黑。浪费四个月，最后小修后拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a35c6157456, createdName=ms4000001493366416, createdTime=Thu Apr 20 17:55:36 CST 2023, time=2023-04-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1014233, encodeId=c452101423379, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：从送审到接收一共4个月，reviewer给的修改意见都满中肯的，推荐大家试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f66f5413873, createdName=ms3000000954628811, createdTime=Fri Sep 03 10:11:06 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582689, encodeId=58b55826898c, content=投稿3个多月了一直就是under review，效率真的低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/02/b5194c05477f149e6bd8f172e1c2828e.jpg, createdBy=7ceb2052413, createdName=Dr_WangBH, createdTime=Sat Jan 04 00:00:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202822, encodeId=f76d1202822f6, content=想问一下大家，投稿3天好分配了主编，然后过了一周又分配了一个associate editor，现在半个月了还在with editor，有这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33995569878, createdName=ms1000001369889276, createdTime=Tue Mar 15 18:20:52 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096193, encodeId=c78e10961930a, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096194, encodeId=0d6b109619431, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-09-03 ms3000000954628811

审稿速度:3.0 | 投稿命中率:50.0
经验分享：从送审到接收一共4个月，reviewer给的修改意见都满中肯的，推荐大家试试

311 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1209512, encodeId=29571209512db, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：2022年1月10日提交；2月18日review结束，大修；3月14修回，第二天送review；4月1日review结束，小修；4月2日修回；4月6日accept。审稿人和编辑都是天使，可能运气太好，没有参考价值。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/36106a7fa35645f6a2c7404a7acbe984/37233b07a082487c8b66591785d9fc87.png, createdBy=7d465433263, createdName=王王王王大腿, createdTime=Fri Apr 08 10:56:00 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800138, encodeId=08f9800138b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：不错的杂志，刚接收了一篇，一审大概1.5个月，给了大修，3个审稿人给的意见很中肯，修回后没过多久就under review，大概10天左右直接accept<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1127, replyNumber=6, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200919/6a097961ca9c42c185295b14179a7194/45794bdef2854b5eac70a38f937a6355.jpg, createdBy=8e512207268, createdName=120c9b2em65(暂无昵称), createdTime=Sun Jun 28 17:02:06 CST 2020, time=2020-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053627, encodeId=67e3105362e9a, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：心血管药物 经验分享：2月份投稿，审稿两个多月，修稿两个多月，两个审稿人的问题也不说清楚，补充实验后，返回编辑，结果拒稿，理由是没有提供原始数据，审稿意见和往来邮件中从来没有提及要提供原始数据，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920b5612598, createdName=ms8000001931272154, createdTime=Wed Sep 22 04:30:06 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146004, encodeId=9fea21460048f, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢;;营养; 经验分享：投稿1月3号 1月13号with editor 2月12日Under review 3月31日修稿通知 6月1日上传修改稿 6月2日-With Editor 6月26日Under review 6月29日决策中 6月30号接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23e45475395, createdName=ms8000000472362345, createdTime=Sun Jul 02 22:41:59 CST 2023, time=2023-07-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127302, encodeId=0c17212e3025d, content=审稿速度:4.0 | 投稿命中率:5.0 经验分享：一生黑。浪费四个月，最后小修后拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a35c6157456, createdName=ms4000001493366416, createdTime=Thu Apr 20 17:55:36 CST 2023, time=2023-04-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1014233, encodeId=c452101423379, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：从送审到接收一共4个月，reviewer给的修改意见都满中肯的，推荐大家试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f66f5413873, createdName=ms3000000954628811, createdTime=Fri Sep 03 10:11:06 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582689, encodeId=58b55826898c, content=投稿3个多月了一直就是under review，效率真的低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/02/b5194c05477f149e6bd8f172e1c2828e.jpg, createdBy=7ceb2052413, createdName=Dr_WangBH, createdTime=Sat Jan 04 00:00:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202822, encodeId=f76d1202822f6, content=想问一下大家，投稿3天好分配了主编，然后过了一周又分配了一个associate editor，现在半个月了还在with editor，有这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33995569878, createdName=ms1000001369889276, createdTime=Tue Mar 15 18:20:52 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096193, encodeId=c78e10961930a, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096194, encodeId=0d6b109619431, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2020-01-04 Dr_WangBH

投稿3个多月了一直就是under review，效率真的低

385 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1209512, encodeId=29571209512db, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：2022年1月10日提交；2月18日review结束，大修；3月14修回，第二天送review；4月1日review结束，小修；4月2日修回；4月6日accept。审稿人和编辑都是天使，可能运气太好，没有参考价值。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/36106a7fa35645f6a2c7404a7acbe984/37233b07a082487c8b66591785d9fc87.png, createdBy=7d465433263, createdName=王王王王大腿, createdTime=Fri Apr 08 10:56:00 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800138, encodeId=08f9800138b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：不错的杂志，刚接收了一篇，一审大概1.5个月，给了大修，3个审稿人给的意见很中肯，修回后没过多久就under review，大概10天左右直接accept<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1127, replyNumber=6, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200919/6a097961ca9c42c185295b14179a7194/45794bdef2854b5eac70a38f937a6355.jpg, createdBy=8e512207268, createdName=120c9b2em65(暂无昵称), createdTime=Sun Jun 28 17:02:06 CST 2020, time=2020-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053627, encodeId=67e3105362e9a, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：心血管药物 经验分享：2月份投稿，审稿两个多月，修稿两个多月，两个审稿人的问题也不说清楚，补充实验后，返回编辑，结果拒稿，理由是没有提供原始数据，审稿意见和往来邮件中从来没有提及要提供原始数据，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920b5612598, createdName=ms8000001931272154, createdTime=Wed Sep 22 04:30:06 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146004, encodeId=9fea21460048f, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢;;营养; 经验分享：投稿1月3号 1月13号with editor 2月12日Under review 3月31日修稿通知 6月1日上传修改稿 6月2日-With Editor 6月26日Under review 6月29日决策中 6月30号接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23e45475395, createdName=ms8000000472362345, createdTime=Sun Jul 02 22:41:59 CST 2023, time=2023-07-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127302, encodeId=0c17212e3025d, content=审稿速度:4.0 | 投稿命中率:5.0 经验分享：一生黑。浪费四个月，最后小修后拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a35c6157456, createdName=ms4000001493366416, createdTime=Thu Apr 20 17:55:36 CST 2023, time=2023-04-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1014233, encodeId=c452101423379, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：从送审到接收一共4个月，reviewer给的修改意见都满中肯的，推荐大家试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f66f5413873, createdName=ms3000000954628811, createdTime=Fri Sep 03 10:11:06 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582689, encodeId=58b55826898c, content=投稿3个多月了一直就是under review，效率真的低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/02/b5194c05477f149e6bd8f172e1c2828e.jpg, createdBy=7ceb2052413, createdName=Dr_WangBH, createdTime=Sat Jan 04 00:00:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202822, encodeId=f76d1202822f6, content=想问一下大家，投稿3天好分配了主编，然后过了一周又分配了一个associate editor，现在半个月了还在with editor，有这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33995569878, createdName=ms1000001369889276, createdTime=Tue Mar 15 18:20:52 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096193, encodeId=c78e10961930a, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096194, encodeId=0d6b109619431, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-03-15 ms1000001369889276

想问一下大家，投稿3天好分配了主编，然后过了一周又分配了一个associate editor，现在半个月了还在with editor，有这种情况吗

124 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1209512, encodeId=29571209512db, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：2022年1月10日提交；2月18日review结束，大修；3月14修回，第二天送review；4月1日review结束，小修；4月2日修回；4月6日accept。审稿人和编辑都是天使，可能运气太好，没有参考价值。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/36106a7fa35645f6a2c7404a7acbe984/37233b07a082487c8b66591785d9fc87.png, createdBy=7d465433263, createdName=王王王王大腿, createdTime=Fri Apr 08 10:56:00 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800138, encodeId=08f9800138b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：不错的杂志，刚接收了一篇，一审大概1.5个月，给了大修，3个审稿人给的意见很中肯，修回后没过多久就under review，大概10天左右直接accept<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1127, replyNumber=6, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200919/6a097961ca9c42c185295b14179a7194/45794bdef2854b5eac70a38f937a6355.jpg, createdBy=8e512207268, createdName=120c9b2em65(暂无昵称), createdTime=Sun Jun 28 17:02:06 CST 2020, time=2020-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053627, encodeId=67e3105362e9a, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：心血管药物 经验分享：2月份投稿，审稿两个多月，修稿两个多月，两个审稿人的问题也不说清楚，补充实验后，返回编辑，结果拒稿，理由是没有提供原始数据，审稿意见和往来邮件中从来没有提及要提供原始数据，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920b5612598, createdName=ms8000001931272154, createdTime=Wed Sep 22 04:30:06 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146004, encodeId=9fea21460048f, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢;;营养; 经验分享：投稿1月3号 1月13号with editor 2月12日Under review 3月31日修稿通知 6月1日上传修改稿 6月2日-With Editor 6月26日Under review 6月29日决策中 6月30号接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23e45475395, createdName=ms8000000472362345, createdTime=Sun Jul 02 22:41:59 CST 2023, time=2023-07-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127302, encodeId=0c17212e3025d, content=审稿速度:4.0 | 投稿命中率:5.0 经验分享：一生黑。浪费四个月，最后小修后拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a35c6157456, createdName=ms4000001493366416, createdTime=Thu Apr 20 17:55:36 CST 2023, time=2023-04-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1014233, encodeId=c452101423379, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：从送审到接收一共4个月，reviewer给的修改意见都满中肯的，推荐大家试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f66f5413873, createdName=ms3000000954628811, createdTime=Fri Sep 03 10:11:06 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582689, encodeId=58b55826898c, content=投稿3个多月了一直就是under review，效率真的低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/02/b5194c05477f149e6bd8f172e1c2828e.jpg, createdBy=7ceb2052413, createdName=Dr_WangBH, createdTime=Sat Jan 04 00:00:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202822, encodeId=f76d1202822f6, content=想问一下大家，投稿3天好分配了主编，然后过了一周又分配了一个associate editor，现在半个月了还在with editor，有这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33995569878, createdName=ms1000001369889276, createdTime=Tue Mar 15 18:20:52 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096193, encodeId=c78e10961930a, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096194, encodeId=0d6b109619431, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-12-28 学医的彭于晏

引言需要写什么内容？

199 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1209512, encodeId=29571209512db, content=审稿速度:3.0 | 投稿命中率:95.0 经验分享：2022年1月10日提交；2月18日review结束，大修；3月14修回，第二天送review；4月1日review结束，小修；4月2日修回；4月6日accept。审稿人和编辑都是天使，可能运气太好，没有参考价值。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210901/36106a7fa35645f6a2c7404a7acbe984/37233b07a082487c8b66591785d9fc87.png, createdBy=7d465433263, createdName=王王王王大腿, createdTime=Fri Apr 08 10:56:00 CST 2022, time=2022-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800138, encodeId=08f9800138b4, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：不错的杂志，刚接收了一篇，一审大概1.5个月，给了大修，3个审稿人给的意见很中肯，修回后没过多久就under review，大概10天左右直接accept<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1127, replyNumber=6, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200919/6a097961ca9c42c185295b14179a7194/45794bdef2854b5eac70a38f937a6355.jpg, createdBy=8e512207268, createdName=120c9b2em65(暂无昵称), createdTime=Sun Jun 28 17:02:06 CST 2020, time=2020-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1053627, encodeId=67e3105362e9a, content=审稿速度:12.0 | 投稿命中率:5.0 偏重的研究方向：心血管药物 经验分享：2月份投稿，审稿两个多月，修稿两个多月，两个审稿人的问题也不说清楚，补充实验后，返回编辑，结果拒稿，理由是没有提供原始数据，审稿意见和往来邮件中从来没有提及要提供原始数据，太坑了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=299, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920b5612598, createdName=ms8000001931272154, createdTime=Wed Sep 22 04:30:06 CST 2021, time=2021-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2146004, encodeId=9fea21460048f, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：代谢;;营养; 经验分享：投稿1月3号 1月13号with editor 2月12日Under review 3月31日修稿通知 6月1日上传修改稿 6月2日-With Editor 6月26日Under review 6月29日决策中 6月30号接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23e45475395, createdName=ms8000000472362345, createdTime=Sun Jul 02 22:41:59 CST 2023, time=2023-07-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2127302, encodeId=0c17212e3025d, content=审稿速度:4.0 | 投稿命中率:5.0 经验分享：一生黑。浪费四个月，最后小修后拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a35c6157456, createdName=ms4000001493366416, createdTime=Thu Apr 20 17:55:36 CST 2023, time=2023-04-20, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1014233, encodeId=c452101423379, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：从送审到接收一共4个月，reviewer给的修改意见都满中肯的，推荐大家试试, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f66f5413873, createdName=ms3000000954628811, createdTime=Fri Sep 03 10:11:06 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582689, encodeId=58b55826898c, content=投稿3个多月了一直就是under review，效率真的低, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/02/b5194c05477f149e6bd8f172e1c2828e.jpg, createdBy=7ceb2052413, createdName=Dr_WangBH, createdTime=Sat Jan 04 00:00:00 CST 2020, time=2020-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202822, encodeId=f76d1202822f6, content=想问一下大家，投稿3天好分配了主编，然后过了一周又分配了一个associate editor，现在半个月了还在with editor，有这种情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=33995569878, createdName=ms1000001369889276, createdTime=Tue Mar 15 18:20:52 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096193, encodeId=c78e10961930a, content=引言需要写什么内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096194, encodeId=0d6b109619431, content=引言中文章的创新性如何体现？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-12-29 ms6000000264964247

引言中文章的创新性如何体现？

209 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务